WO2026057013 - DENGUE VIRUS REPLICATION INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2026/057013
Publication Date
19.03.2026
International Application No.
PCT/CN2025/120914
International Filing Date
12.09.2025
Title **
[English]
DENGUE VIRUS REPLICATION INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF
[French]
INHIBITEUR DE LA RÉPLICATION DU VIRUS DE LA DENGUE, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION
[Chinese]
一类登革热病毒复制抑制剂、其制备方法和用途
Applicants **
HUAWU BIOMEDICAL TECHNOLOGY (HUBEI) CO., LTD.
Inventors
YU, Feilong
JU, Jing
XU, Chang
XIAO, Yu
LIU, Yingwei
Priority Data
202411295599.6
14.09.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1614 | |
| EPO | Filing, Examination, Granting | 11804 | |
| Japan | Filing, Examination, Granting | 2020 | |
| South Korea | Filing, Examination, Granting | 1790 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
21,968
Contact Us
Abstract[English]
The present invention provides a novel small molecule compound having Dengue virus replication inhibitory activity, relates to a compound represented by formula (II), a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, a preparation method therefor, and the use of the compound, and belongs to the field of medicinal chemistry.[French]
La présente invention concerne un nouveau composé à petites molécules ayant une activité inhibitrice de la réplication du virus de la dengue, concerne un composé représenté par la formule (II), un stéréoisomère, un tautomère ou un sel pharmaceutiquement acceptable de celui-ci, son procédé de préparation et l'utilisation du composé, et appartient au domaine de la chimie médicale.[Chinese]
本发明提供一类新的具有登革热病毒复制抑制活性的小分子化合物，涉及式(Ⅱ)所示的化合物、其立体异构体、互变异构体或其可药用盐及其制备方法，以及这类化合物的用途，属于医药化学领域